Synthesis, proapoptotic screening, and structure-activity relationships of novel aza-lupane triterpenoids

Aye Aye Mar1, Erika L Szotek, Ali Koohang

  • 1Advanced Life Sciences, Inc., 1440 Davey Road, Woodridge, IL 60517, United States.

Insights

Novel aza-lupane triterpenoids show enhanced antitumor activity by inducing apoptosis. Specific bis(aza) derivatives are more effective than betulinic acid, highlighting their therapeutic potential in oncology.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Apoptosis is a crucial cellular process for tissue homeostasis and preventing diseases like cancer.
  • Dysregulation of apoptosis contributes to cancer development and treatment resistance.
  • Targeting apoptotic pathways is a key strategy in oncology drug discovery.

Purpose of the Study:

  • To design, synthesize, and evaluate novel aza-lupane triterpenoids for antitumor activity.
  • To investigate the ability of these compounds to induce apoptosis in cancer cells.
  • To compare the efficacy and mechanism of action of mono(aza) and bis(aza) derivatives.

Main Methods:

  • Synthesis of novel aza-lupane triterpenoids.
  • Antitumor activity evaluation against diverse cancer cell lines.
  • Apoptosis induction assays.
  • Comparative analysis with betulinic acid.

Main Results:

  • Aza-lupane triterpenoids demonstrated significant antitumor activity.
  • 3,3'-Bis(aza) derivatives exhibited improved cytotoxicity compared to betulinic acid.
  • Bis(aza) derivatives predominantly induced cell death via apoptosis.
  • Mono(aza) derivatives triggered cell death through non-apoptotic pathways.

Conclusions:

  • Novel aza-lupane triterpenoids, particularly bis(aza) derivatives, represent promising candidates for cancer therapy.
  • These compounds effectively induce apoptosis, offering a targeted approach for cancer treatment.
  • Understanding the distinct mechanisms of mono- and bis(aza) derivatives can guide future drug development.